Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 3036Generated: October 25, 2026

Pyridine, hydrofluoride (1:1) → methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate

https://huagongshe.com/reaction/3036

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPyridine, hydrofluoride (1:1)HCID 64774—
Reactantmethyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883818—
Productmethyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883815—

Reaction Steps

Using as the materials a hydrogen fluoride-pyridine solution (0.25 ml) and methyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate (100 mg), the same procedure as in Example 2 was performed to separately obtain two stereoisomers of methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate different at the 15-position. (Low polarity compound: 26 mg, 33%; high polarity compound: 28 mg, 35%)

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05731452
Source datasetuspto-grants-1998_03
ORD IDord-e387f53034b342bebeac204bcb29c54a
Source noteuspto-grants-1998_03